Advertisement
U.S. markets closed
Advertisement

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.7800-0.0600 (-3.26%)
At close: 03:41PM EST
1.9100 +0.11 (+6.11%)
After hours: 07:49PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
Operating Expense
25,766
25,797
19,288
9,785
8,619
Operating Income
-25,766
-25,797
-19,288
-9,785
-8,619
Net Non Operating Interest Income Expense
-
821
-208
219
231
Other Income Expense
-2,633
-6,084
5,028
-2,258
-996
Pretax Income
-28,607
-31,060
-14,468
-11,824
-9,384
Net Income Common Stockholders
-28,607
-31,060
-14,468
-11,824
-9,582
Diluted NI Available to Com Stockholders
-28,607
-31,060
-14,468
-11,824
-9,582
Basic EPS
-1.46
-1.69
-0.81
-0.90
-1.11
Diluted EPS
-1.46
-1.69
-0.81
-0.90
-1.11
Basic Average Shares
18,484
18,395
17,860
13,169
8,649
Diluted Average Shares
18,484
18,395
17,860
13,169
8,649
Total Operating Income as Reported
-25,766
-25,797
-19,288
-9,785
-8,619
Total Expenses
25,766
25,797
19,288
9,785
8,619
Net Income from Continuing & Discontinued Operation
-28,607
-31,060
-14,468
-11,824
-9,384
Normalized Income
-33,635
-24,976
-19,496
-9,566
-8,388
Interest Income
-
835
120
225
238
Net Interest Income
-
821
-208
219
231
EBIT
-25,766
-25,797
-19,288
-9,785
-8,619
EBITDA
-25,060
-25,020
-18,742
-9,499
-8,413
Reconciled Depreciation
706
777
546
286
206
Net Income from Continuing Operation Net Minority Interest
-28,607
-31,060
-14,468
-11,824
-9,384
Total Unusual Items Excluding Goodwill
5,028
-6,084
5,028
-2,258
-996
Total Unusual Items
5,028
-6,084
5,028
-2,258
-996
Normalized EBITDA
-30,088
-18,936
-23,770
-7,241
-7,417
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0